

Sheyn Lab
933 posts

@SheynLab
Orthopedic Stem Cell Research Lab of Dmitriy Sheyn develops disease models and stem cell therapies #Spine #Tendon https://t.co/skdqDdJ3MX












Breaking: Capricor is extremely pleased to announce positive topline results from our pivotal Phase 3 HOPE-3 clinical study evaluating Deramiocel in Duchenne muscular dystrophy. HOPE-3 met its primary endpoint and key cardiac secondary endpoint, with all Type 1 error–controlled secondary endpoints also achieving statistical significance. Deramiocel maintained a favorable safety and tolerability profile consistent with prior studies. We are grateful to the patients, families, investigators and partners who made this milestone possible. Read the full announcement: bit.ly/3Ko9KV6 Join our conference call and webcast today at 8:00 a.m. ET. bit.ly/48O3SOb $CAPR #Duchenne #DMD #Deramiocel #HOPE3 #CellTherapy #RareDiseaseAdvocate











🚨 Final Day! 🚨 Abstract submissions for the #ORS2026 Annual Meeting close today, August 25 at 11:59 PM Central. Don’t miss your chance to share your work at our organization’s most important event, March 27–31 in Charlotte, NC. Submit your abstract now: ors.org/2026abstracts/